TY - JOUR
T1 - Lung transplantation from uncontrolled and controlled donation after circulatory death
T2 - similar outcomes to brain death donors
AU - Campo-Cañaveral de la Cruz, Jose Luis
AU - Crowley Carrasco, Silvana
AU - Tanaka, Shin
AU - Romero Román, Alejandra
AU - Hoyos Mejía, Lucas
AU - Gil Barturen, Mariana
AU - Sánchez Calle, Álvaro
AU - García Fadul, Christian
AU - Aguilar Pérez, Myriam
AU - Pérez Redondo, Marina
AU - Naranjo Gómez, Jose Manuel
AU - Royuela, Ana
AU - Córdoba Peláez, Mar
AU - Varela de Ugarte, Andrés
AU - Gómez de Antonio, David
N1 - Publisher Copyright:
© 2021 The Authors. Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT
PY - 2021
Y1 - 2021
N2 - Controlled donation after circulatory death donors (cDCD) are becoming a frequent source of lungs grafts worldwide. Conversely, lung transplantations (LTx) from uncontrolled donors (uDCD) are sporadically reported. We aimed to review our institutional experience using both uDCD and cDCD and compare to LTx from brain death donors (DBD). This is a retrospective analysis of all LTx performed between January 2013 and December 2019 in our institution. Donor and recipient characteristics were collected and univariate, multivariate and survival analyses were carried out comparing the three cohorts of donors. A total of 239 (84.7%) LTx were performed from DBD, 29 (10.3%) from cDCD and 14 (5%) from uDCD. There were no statistically significant differences in primary graft dysfunction grade 3 at 72 h, 30- and 90-day mortality, need for extracorporeal membrane oxygenation after procedure, ICU and hospital length of stay, airway complications, CLAD incidence or survival at 1 and 3 years after transplant (DBD: 87.1% and 78.1%; cDCD: 89.7% and 89.7%; uDCD: 85.7% and 85.7% respectively; P = 0.42). Short- and mid-term outcomes are comparable between the three types of donors. These findings may encourage and reinforce all types of donation after circulatory death programmes as a valid and growing source of suitable organs for transplantation.
AB - Controlled donation after circulatory death donors (cDCD) are becoming a frequent source of lungs grafts worldwide. Conversely, lung transplantations (LTx) from uncontrolled donors (uDCD) are sporadically reported. We aimed to review our institutional experience using both uDCD and cDCD and compare to LTx from brain death donors (DBD). This is a retrospective analysis of all LTx performed between January 2013 and December 2019 in our institution. Donor and recipient characteristics were collected and univariate, multivariate and survival analyses were carried out comparing the three cohorts of donors. A total of 239 (84.7%) LTx were performed from DBD, 29 (10.3%) from cDCD and 14 (5%) from uDCD. There were no statistically significant differences in primary graft dysfunction grade 3 at 72 h, 30- and 90-day mortality, need for extracorporeal membrane oxygenation after procedure, ICU and hospital length of stay, airway complications, CLAD incidence or survival at 1 and 3 years after transplant (DBD: 87.1% and 78.1%; cDCD: 89.7% and 89.7%; uDCD: 85.7% and 85.7% respectively; P = 0.42). Short- and mid-term outcomes are comparable between the three types of donors. These findings may encourage and reinforce all types of donation after circulatory death programmes as a valid and growing source of suitable organs for transplantation.
KW - brain death donors
KW - controlled donors after circulatory death
KW - early mortality
KW - lung transplantation
KW - overall survival
KW - uncontrolled donors after circulatory death
UR - http://www.scopus.com/inward/record.url?scp=85117489603&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117489603&partnerID=8YFLogxK
U2 - 10.1111/tri.14120
DO - 10.1111/tri.14120
M3 - Article
C2 - 34570381
AN - SCOPUS:85117489603
SN - 0934-0874
JO - Transplant International
JF - Transplant International
ER -